Algo version: 0.98b
Kuros Biosciences AG is listed at the SIX Exchange
Kuros Biosciences AG [KURN.SW]
SIX Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Kuros Biosciences AG stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Kuros Biosciences AG 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CHF1.433, you would have made a profit of CHF15.35 per share or 1 070.96%

Yes, the average daily trading liquidity for Kuros Biosciences AG is CHF260 540 thousand. You should therefore be able to get in and out of your positions relatively fast.

Kuros Biosciences AG has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Kuros Biosciences AG to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.